• Topics
    • AI & Big Data
    • AR & VR
    • Blockchain
    • Clean Technology
    • Content & Games
    • Cybersecurity
    • Enterprise & SaaS
    • FinTech
    • Gadgets & Electronics
    • Health & Bio
    • Manufacturing
    • IoT
    • Marketplaces & E-commerce
    • Robotics
    • Transportation & Logistics
    • Investments
    • Ecosystem & Lists
  • Interviews
  • Events
    • ComeUp
    • NextRise
  • Governments
    • Korea Internet & Security Agency
    • Korea Institute of Startup & Entrepreneurship Development
    • Korea Creative Content Agency
    • Korea Trade-Investment Promotion Agency
    • Korea Tourism Organization
    • Ministry of SMEs & Startups
    • National IT Industry Promotion Agency
    • Seoul Business Agency
    • Seoul FinTech Lab
    • Pangyo Techno Valley
    • Gyeonggido Business & Science Accelerator
  • Programs
    • SGSC Global Bootcamp 2021
    • LAUNCHPAD
    • COMEUP STARS 120
    • K-Startup Grand Challenge
    • TIPS X beSUCCESS Global Project
    • SFL Global Program
    • KTO Global Showcase
  • Investment Opportunities
    • SGSC Demo Day
    • Launchpad France Demoday
    • TIPS Global Demoday
    • Launchpad USA Demoday
    • Launchpad Indonesia Demoday
  • Business Agencies
    • Accounting Firms
    • Ads & Marketing
    • Law Firms
  • Submit an Article
  • Profile
    • My Articles
    • Create your Startup Profile
    • My companies
    • My Points
    • My Saved Deals
    • Logout
KoreaTechDesk
No Result
View All Result
KoreaTechDesk
No Result
View All Result
Home Health & Bio

Standigm: Applying Artificial Intelligence to Improve Drug Discovery Research

KoreaTechDesk Writer by KoreaTechDesk Writer
December 24, 2018
in Health & Bio
1
Standigm: Applying Artificial Intelligence to Improve Drug Discovery Research
1
SHARES
0
VIEWS
Share on FacebookShare on Twitter

In the field of pharmaceutical research and development, it can take years and even decades to discover new drugs. The research cost can also reach billions of dollars. Considering this problem, a Korean startup Standigm has been working towards improving pharmaceutical development processes by integrating Artificial Intelligence with systems biology technology to discover drugs. The startup recently launched its latest service Standigm BEST, a technology that provides better novel structures, at the 24th annual BIO-Europe international partnering conference.

Reducing Cost and Saving Time with AI

The services by Standigm reduces the traditional trial and error time to a large extent by using innovative AI, that automatically examines whole biomedical databases to learn what is hiding just out of sight. By using Standigm’s state-of-the-art machine learning technology, pharma research companies can eliminate some of the uncertainty in the drug discovery process. This enables focused research for effective treatments.

‘Standigm discovers drugs using AI,

saving time and cost when compared to traditional methods.’

Standigm BEST launched recently is an AI-driven customer-friendly service that generates better novel structures and provides lead optimisation to improve customer’s desired properties such as potency, selectivity, and ADMET (Adsorption, Distribution, Metabolism, Excretion, and Toxicity). Standigm BEST also helps with fast-follow hit identification or patent fencing strategies.

“Standigm BEST has piqued the interest of pharmaceutical companies, and the company has scheduled various meetings with several leading pharmaceutical companies,” Standigm co-founder and CEO Kim Jinhan Kim told the media.

Strong Foundation with Brilliant Team

In November 2017, the company had launched another AI-driven drug repurposing service called Standigm Expander. “We have gained recognition for our AI technology by providing the Expander service,” Kim said. “Through such recognition, the company is increasing employment to meet the demands from pharmaceutical companies and develop more advanced AI technology.”

Standigm has a brilliant team of experts in systems biology, AI and systems engineering. CEO Jinhan Kim has worked on AI and machine learning research extensively. Directors Sang Ok Song and So Jeong Yoon have vast experience in biochemical engineering and systems biology/bioinformatics research in their careers.  In 2016 the company raised $3 million investments from LB Investment, K Cube Ventures, and Atinum Investment.

Standigm with its expert and experienced team has the vision to bring groundbreaking technological changes to the field of drug discovery and research.

What’s your thoughts?
+1
0
Upvote
+1
0
Clap
+1
0
Clap
+1
0
On fire
+1
0
Meh
+1
0
Clap
+1
0
Tags: Artificial IntelligenceBiotechPharma ResearchPharmaceuticalsStartupTIPS
Previous Post

I.M.Labs –  Helping people who help to save lives with innovative products

Next Post

Orum Therapeutics’ new medicines can treat cancer and assist in genetic diseases

Next Post
Orum Therapeutics’ new medicines can treat cancer and assist in genetic diseases

Orum Therapeutics’ new medicines can treat cancer and assist in genetic diseases

0 0 votes
Article Rating
Subscribe
Login
Notify of
Please login to comment
1 Comment
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
trackback
สมัครสมาชิกyehyeh
14 days ago

… [Trackback]

[…] Find More to that Topic: koreatechdesk.com/standigm-applying-artificial-intelligence-to-improve-drug-discovery-research/ […]

0
No Result
View All Result

FREE NEWSLETTER

Ecosystem Partners

Follow Us




PRODUCTS

Most Popular

    Copyright © 2023 KoreaTechDesk | About Us | Our Services| Terms of Use |Privacy Policy |Cookie Policy Contact: [email protected] DMCA.com Protection Status

    No Result
    View All Result
    • Topics
      • AI & Big Data
      • AR & VR
      • Blockchain
      • Clean Technology
      • Content & Games
      • Cybersecurity
      • Enterprise & SaaS
      • FinTech
      • Gadgets & Electronics
      • Health & Bio
      • Manufacturing
      • IoT
      • Marketplaces & E-commerce
      • Robotics
      • Transportation & Logistics
      • Investments
      • Ecosystem & Lists
    • Interviews
    • Events
      • ComeUp
      • NextRise
    • Governments
      • Korea Internet & Security Agency
      • Korea Institute of Startup & Entrepreneurship Development
      • Korea Creative Content Agency
      • Korea Tourism Organization
      • Korea Trade-Investment Promotion Agency
      • Ministry of SMEs & Startups
      • National IT Industry Promotion Agency
      • Seoul Business Agency
      • Seoul FinTech Lab
      • Pangyo Techno Valley
      • Gyeonggido Business & Science Accelerator
    • Programs
      • LAUNCHPAD
      • COMEUP STARS 120
      • K-Startup Grand Challenge
      • TIPS X beSUCCESS Global Project
      • SFL Global Program
      • KTO Global Showcase
    • Investment Opportunities
      • Launchpad France Demoday
      • TIPS Global Demoday
      • Launchpad USA Demoday
      • Launchpad Indonesia Demoday
    • Business Agencies
      • Accounting Firms
      • Ads & Marketing
      • Law Firms
    • Submit an Article
    • Forums
    • Profile
    • My Articles
    • Create your Startup Profile
    • My companies
    • My Points
    • My Saved Deals
    • Logout
    • register
    • login

    Copyright © 2023 KoreaTechDesk | About Us | Our Services| Terms of Use |Privacy Policy |Cookie Policy Contact: [email protected] DMCA.com Protection Status

    wpDiscuz
    1
    0
    Would love your thoughts, please comment.x
    ()
    x
    | Reply
    Our Spring Sale Has Started

    You can see how this popup was set up in our step-by-step guide: https://wppopupmaker.com/guides/auto-opening-announcement-popups/

    We hope you enjoy our content, May you please give us Feedback regarding our website!

    Single Post Feedback

    dgdfgfdgdf

    Invitation submission has been closed

    Insert/edit link

    Enter the destination URL

    Or link to existing content

      No search term specified. Showing recent items. Search or use up and down arrow keys to select an item.